Clinical studies have shown that tirzepatide can lead to significant weight loss in adults with obesity or overweight, even in people without diabetes
You develop severe or persistent gastrointestinal symptoms after starting Mounjaro, including ongoing nausea, vomiting, diarrhoea, or abdominal pain
This creates a reinforcing cycle: poor gut integrity worsens immune dysregulation, which drives more inflammation, which further damages the gut
Pioglitazone is recommended as a second-line hypoglycemic therapy when HbA1c is still above the target level
Dysfunctional adipose tissue has a detrimental impact on metabolic health and is intimately involved in key aspects of metabolic diseases such as insulin resistance, lipid overload, inflammation, and organelle stress
This guide provides evidence-based strategies for managing Mounjaro GI side effects effectively